Chennai, July 9, 2025 – Apollo AyurVAID, India’s leading NABH-accredited precision Ayurveda hospital network, has announced its entry into the Ayurveda product market, marking a significant expansion beyond clinical care.
Pioneering a New Benchmark in Ayurveda Product Safety
Apollo AyurVAID’s newly launched portfolio spans classical formulations, over-the-counter (OTC) products, and medical foods—addressing the rising demand for clinically validated, safe Ayurveda solutions in India’s rapidly growing ₹60,000 crore market, which is expanding at over 16% annually.
For the first time in the industry, these products are certified “Tested Safe” by NABL-accredited labs, screened for heavy metals, aflatoxins, microbial content, and other relevant safety parameters. Each product carries a QR code-enabled transparency feature that allows consumers to access individual lab test reports—establishing a new standard of accountability and safety in Ayurveda.
Leadership Speaks: A New Era for Ayurveda
Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals & Chairperson, Apollo AyurVAID, commented:
“Apollo AyurVAID’s foray into tested-safe Ayurveda products marks a pivotal step in redefining standards of safety, transparency, and efficacy in traditional medicine. This expansion builds on clinical excellence and represents our deep commitment to evidence-based, precision Ayurveda.”
Strategic Growth with Global Vision
Mr. Rajiv Vasudevan, Founder, MD & CEO of Apollo AyurVAID, emphasized the strategic importance of this move:
“With two decades of clinical excellence, we’re now entering a high-potential consumer segment. This vertical will strengthen our care model and unlock scalable revenue. Our aim is to reach ₹500 crore in revenue from this segment in the next five years.”
Multi-Segment Product Portfolio
Apollo AyurVAID’s product lines are designed to cater to diverse customer needs:
-
Classical Formulations – available via prescription
-
OTC & Medical Foods – accessible through retail and digital channels
-
Innovative Formats – including creams, transdermal pads, essential extracts for segments such as women, children, and the elderly
-
Focus Areas – pain, stress, sleep, skin health, and more
The OTC line ensures high medical content, promising best-in-class product efficacy.
Scientific Collaborations for Evidence-Based Products
Apollo AyurVAID has partnered with Avesthagen Limited, a leading systems biology platform, to co-develop AvestaAyurVAID—a line of scientifically validated dietary supplements. These products are sugar-free, and free from artificial colours and flavours, with upcoming launches targeting specific clinical indications through Ayurveda-based medical foods.
Brand Architecture: AyurVAID and AvestaAyurVAID
-
‘AyurVAID’ – Branding for classical and OTC products
-
‘AvestaAyurVAID’ – Branding for science-backed dietary supplements
This branding strategy reinforces Apollo AyurVAID’s mission to be a credible, science-led ecosystem for precision Ayurveda, evolving into a full-spectrum Ayurveda company.
Ambitious Expansion Plans
Apollo AyurVAID plans aggressive growth in the current fiscal:
-
9 new points of presence through an asset-light model
-
350-bed capacity
-
Target: 50,000 patients annually
With a CAGR of 75% over the past 2–3 years, Apollo AyurVAID is set to cross the ₹100 crore revenue milestone by mid-next year—an unprecedented feat in the Ayurveda services sector.
“This is just the beginning of our journey to take Apollo AyurVAID, India’s most credible precision Ayurveda brand, to every corner of the country and beyond,” concluded Mr. Vasudevan.
